🟢 Neurosense Therapeutics is trading 12% up in after-hours trading with no confirmed catalyst

Neurosense Therapeutics is trading at $0.43, up 12.02% in after-hours trading, with no confirmed company-specific catalyst.

• It closed at $0.38 on August 18, 2026, after an 11.57% regular-session decline; no confirmed company-specific announcement was identified for August 18.
• The broader market was risk-off, with technology shares and major indexes falling, but the opposite-direction rebound does not establish a macro cause.
• The latest indexed update was an August 13 CEO shareholder letter; the move appears speculative or liquidity-driven.